[HTML][HTML] Real-life validation of the Panbio™ COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection

…, AMJ Wensing, MJM Bonten, LM Hofstra - …, 2021 - thelancet.com
Background RT-qPCR is the reference test for identification of active SARS-CoV-2 infection,
but is associated with diagnostic delay. Antigen detection assays can generate results within …

Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe

LM Hofstra, N Sauvageot, J Albert… - Clinical infectious …, 2016 - academic.oup.com
Background. Numerous studies have shown that baseline drug resistance patterns may
influence the outcome of antiretroviral therapy. Therefore, guidelines recommend drug …

[HTML][HTML] SCOPE enables type III CRISPR-Cas diagnostics using flexible targeting and stringent CARF ribonuclease activation

…, BJF Keijser, M Ossendrijver, LM Hofstra… - Nature …, 2021 - nature.com
Characteristic properties of type III CRISPR-Cas systems include recognition of target RNA
and the subsequent induction of a multifaceted immune response. This involves sequence-…

Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study

…, S Carmona, DE Grobbee, LM Hofstra… - The Lancet infectious …, 2018 - thelancet.com
Background Antiretroviral therapy (ART) that enables suppression of HIV replication has
been successfully rolled out at large scale to HIV-positive patients in low-income and middle-…

Lower Incidence of HIV-1 Blips Observed During Integrase Inhibitor–Based Combination Antiretroviral Therapy

S Dijkstra, LM Hofstra, T Mudrikova… - JAIDS Journal of …, 2022 - journals.lww.com
Background: As the nature of viral blips remains unclear, their occurrence often leads to
uncertainty. This study compares blip incidence rates during treatment with different combination …

Integrated analysis of viral blips, residual viremia, and associated factors in people with HIV: Results from a retrospective cohort study

PGA Oomen, S Dijkstra, LM Hofstra… - Journal of Medical …, 2023 - Wiley Online Library
The etiology of viral blips is not yet fully elucidated. One of the hypotheses is that blips
reflect variations in residual viremia (RV) near the detectability threshold. In this study, we …

High rates of transmission of drug-resistant HIV in Aruba resulting in reduced susceptibility to the WHO recommended first-line regimen in nearly half of newly …

LM Hofstra, E Sánchez Rivas, M Nijhuis… - Clinical Infectious …, 2017 - academic.oup.com
Background. In Western countries emergence of human immunodeficiency virus (HIV) drug
resistance has tremendously decreased, and transmission of drug resistance has merely …

In-depth characterization of vaccine breakthrough infections with SARS-CoV-2 among health care workers in a Dutch academic medical center

…, R Schuurman, T Reinders, LM Hofstra… - Open Forum …, 2022 - academic.oup.com
Severe acute respiratory syndrome coronavirus 2 infection after coronavirus disease 2019
vaccination raises concerns about the emergence of vaccine escape variants. Here we …

Evolution and viral characteristics of a long-term circulating resistant HIV-1 strain in a cluster of treatment-naive patients

LM Hofstra, M Nijhuis, M Pingen… - Journal of …, 2013 - academic.oup.com
Background Transmitted resistant HIV may revert to wild-type in the absence of drug
pressure due to reduced replication capacity (RC). We observed eight therapy-naive patients …

[HTML][HTML] Residual viremia is preceding viral blips and persistent low-level viremia in treated HIV-1 patients

LM Hofstra, T Mudrikova, AJ Stam, S Otto… - PLoS …, 2014 - journals.plos.org
Background It has been suggested that low-level viremia or blips in HIV-infected patients on
antiretroviral treatment are related to assay variation and/or increased sensitivity of new …